Enoxaparin-Induced Alopecia in Patients with Cerebral Venous Thrombosis

    Y.‐Y. Wang, Helen L. Po
    Image of study
    TLDR Some patients lost hair after being treated with the drug enoxaparin for a brain vein clot.
    The document describes three cases where female patients with cerebral venous thrombosis developed alopecia after being treated with enoxaparin, a low-molecular-weight heparin. The patients were given 1 mg/kg of enoxaparin subcutaneously twice daily for 3 weeks, followed by oral warfarin for 6 months. Hair loss began approximately 3 weeks after the start of enoxaparin treatment and resolved within 1 month of stopping the drug. The Naranjo Adverse Drug Reaction Probability Scale indicated a score of 6, suggesting enoxaparin as the probable cause of the hair loss. The report highlights the need for awareness of this potential side effect among healthcare professionals.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results

    Related Community Posts Join

    0 / 0 results
    — no results

    Similar Research

    5 / 85 results